IADVL
Indexed with PubMed and Science Citation Index (E) 
 
Users online: 1097 
     Home | Feedback | Reader Login
About Current Issue Archive Ahead of print Search Instructions Online Submission Subscribe What's New Contact  
  NAVIGATE here  
     Search
     Current Issue
     Submit Article 
     My Preferences 
     Dermatology crossword 

 


Export selected to
Endnote
Reference Manager
Procite
Medlars Format
RefWorks Format
BibTex Format
  Access statistics : Table of Contents
   2018| May-June  | Volume 84 | Issue 3  
    Online since April 13, 2018

 
 
  Archives   Previous Issue   Next Issue   Most popular articles   Most cited articles
 
Hide all abstracts  Show selected abstracts  Export selected to
  Viewed PDF Cited
REVIEW ARTICLES
Epidemiology, treatment and prevention of herpes zoster: A comprehensive review
Elsam Koshy, Lu Mengting, Hanasha Kumar, Wu Jianbo
May-June 2018, 84(3):251-262
DOI:10.4103/ijdvl.IJDVL_1021_16  PMID:29516900
Herpes zoster is a major health burden that can affect individuals of any age. It is seen more commonly among individuals aged ≥50 years, those with immunocompromised status, and those on immunosuppressant drugs. It is caused by a reactivation of varicella zoster virus infection. Cell-mediated immunity plays a role in this reactivation. Fever, pain, and itch are common symptoms before the onset of rash. Post-herpetic neuralgia is the most common complication associated with herpes zoster. Risk factors and complications associated with herpes zoster depend on the age, immune status, and the time of initializing treatment. Routine vaccination for individuals over 60 years has shown considerable effect in terms of reducing the incidence of herpes zoster and post-herpetic neuralgia. Treatment with antiviral drugs and analgesics within 72 hours of rash onset has been shown to reduce severity and complications associated with herpes zoster and post-herpetic neuralgia. This study mainly focuses on herpes zoster using articles and reviews from PubMed, Embase, Cochrane library, and a manual search from Google Scholar. We cover the incidence of herpes zoster, gender distribution, seasonal and regional distribution of herpes zoster, incidence of herpes zoster among immunocompromised individuals, incidence of post-herpetic neuralgia following a zoster infection, complications, management, and prevention of herpes zoster and post-herpetic neuralgia.
  22,349 970 -
Genetic and molecular aspects of androgenetic alopecia
Lizeth Martinez-Jacobo, César D Villarreal-Villarreal, Rocío Ortiz-López, Jorge Ocampo-Candiani, Augusto Rojas-Martínez
May-June 2018, 84(3):263-268
DOI:10.4103/ijdvl.IJDVL_262_17  PMID:29595184
Androgenetic alopecia is the most common form of progressive hair loss in humans. A genetic predisposition and hormonal status are considered as major risk factors for this condition. Several recent advances in molecular biology and genetics have increased our understanding of the mechanisms of hair loss in androgenetic alopecia. We review these advances and examine the trends in the genetic and molecular aspects of androgenetic alopecia.
  9,957 757 -
ORIGINAL ARTICLES
Resistance to anti leprosy drugs in multi-bacillary leprosy: A cross sectional study from a tertiary care centre in eastern Uttar Pradesh, India
Satyendra Kumar Singh, Ajit Kumar, Gopal Nath, Tej Bali Singh, Mukti Nath Mishra
May-June 2018, 84(3):275-279
DOI:10.4103/ijdvl.IJDVL_34_16  PMID:29536982
Background: WHO MDT is the main drug regimen for treating leprosy and has been used for more than three decades. Many cases of relapse of leprosy have been reported, which points towards the emergence of drug resistance with the antileprotic drugs. Objectives: To find the resistance with the antileprotic drugs by detecting the mutations in drug resistance determining region of the rpoB, folP1 and gyrA genes of Mycobacterium leprae. Methods: Leprosy patients with bacterial index ≥2 were included in the study. The slides were further processed to extract genomic DNA, and polymerase chain reactions were performed to amplify the drug resistance determining region (DRDR) of rpoB, folP1 and gyrA genes. The samples in which genes could be amplified were subjected to DNA sequencing to detect mutations. Results: Out of 78 samples rpoB gene was amplified in 39 (50%), folP1 in 32 (41%) and gyrA in 45 (57.7%). In 20 (25.6%) samples no gene was amplified. Only 32 samples of rpoB, 25 samples of folP1 and 38 samples of gyrA gene were included in the study, rest were excluded due to sequencing error. No mutation was seen in rpoB gene and in folP1 gene. In gyrA gene samples mutations were seen in 8 (21%) samples, and were present at codon 91 GCA → GTA (Alanine → Valine). Limitations: Small sample size and less efficient method to detect resistance. Conclusion: Resistance is not a problem with conventional drugs in MDT. It is more common with quinolones.
  6,334 347 -
Association between human leukocyte antigen-DRB1 and human leukocyte antigen-DQB1 alleles and pemphigus vulgaris in Indian patients: A case–control study
Anuradha Priyadarshini, Renu George, Dolly Daniel, Santosh Varughese, Visalakshi Jayaseelan
May-June 2018, 84(3):280-284
DOI:10.4103/ijdvl.IJDVL_1014_16  PMID:29582787
Background: HLA-DRB1*04, -DRB1*08, -DRB1*14, -DQB1*03 and -DQB1*05 are reported to have significant association with pemphigus vulgaris; however, this is partially dependent on ethnicity. This study was done to determine the HLA-DR and -DQ types prevalent in Indian patients with pemphigus vulgaris. Methods: A prospective case–control study was done for a period of 9 months in Christian Medical College Vellore, India. HLA typing was done by PCR-SSOP method in 50 cases and 50 healthy controls. Allele frequencies in cases and controls were compared and odds ratios with 95% confidence interval were calculated. Results: The mean age of the patients (29 females, 21 males) and that of controls (36 males, 14 females) were 41.3 ± 13.65 and 35.42 ± 11.09 years, respectively. HLA-DRB1*14 was present in 47 patients and 18 controls (OR, 27.85; 95% CI, 7.57–102.42) and HLA-DQB1*05 was seen in 47 patients and 24 controls (OR, 16.97; 95% CI, 4.66–61.80). The haplotype DRB1*14, DQB1*05 was present in 44 patients and 14 controls (OR, 18.86; 95% CI, 6.58–54.05). DRB1*15 was present in 7 cases and 16 controls (OR, 0.35; 95% CI, 0.13–0.94) and DQB1*06 was present in 8 cases and 19 controls (OR, 0.31; 95% CI, 0.12–0.80). HLA-DQB1*03 was associated with significantly higher pemphigus disease area index scores. Limitations: The main limitations were that the numbers studied were small as the study was conducted at a single center, and the haplotype analysis was limited only to the proband. PDAI scores could have been influenced by prior treatment. Conclusion: There was a significant association between HLA-DRB1*14 and HLA-DQB1*05 and pemphigus vulgaris in our patients. A negative association was seen with DRB1*15 and DQB1*06.
  4,658 103 -
LETTERS TO THE EDITOR - STUDY LETTERS
A review of pulse therapy in 74 patients with pemphigus
Gillian Roga, Mary Augustine
May-June 2018, 84(3):331-333
DOI:10.4103/ijdvl.IJDVL_175_17  PMID:29600798
  4,341 90 -
LETTERS TO THE EDITOR - OBSERVATION LETTERS
Whole exome sequencing in a multi-generation family from India reveals a genetic variation c.10C>T (p.Gln4Ter) in keratin 5 gene associated with Dowling–Degos disease
Neha Virmani, Shamsudheen Karuthedath Vellarikkal, Ankit Verma, Rijith Jayarajan, Jagdish Sakhiya, Chirag Desai, Sridhar Sivasubbu, Vinod Scaria
May-June 2018, 84(3):344-346
DOI:10.4103/ijdvl.IJDVL_268_17  PMID:29600799
  4,171 74 -
LETTERS TO THE EDITOR - CASE LETTERS
A case of cutaneous focal bilirubin deposition in a man with jaundice
Afzaal Ahmed Bin Jameel, Bing Rong Zhou, Ji Ping Xia
May-June 2018, 84(3):320-322
DOI:10.4103/ijdvl.IJDVL_243_16  PMID:29582791
  4,181 42 -
Papillary eccrine adenoma associated with syringocystadenoma papilliferum
Neha Meena, Prafulla Kumar Sharma, Sawan Kumar, Minakshi Bhardwaj
May-June 2018, 84(3):322-324
DOI:10.4103/ijdvl.IJDVL_187_17  PMID:29582790
  4,103 53 -
ORIGINAL ARTICLES
Protective effects of glutamine on human melanocyte oxidative stress model
Liya Jiang, Zhen Guo, Yulong Kong, Jianhua Liang, Yi Wang, Keyu Wang
May-June 2018, 84(3):269-274
DOI:10.4103/ijdvl.IJDVL_106_17  PMID:29491190
Background: Vitiligo is a disorder caused by the loss of the melanocyte activity on melanin pigment generation. Studies show that oxidative-stress induced apoptosis in melanocytes is closely related to the pathogenesis of vitiligo. Glutamine is a well known antioxidant with anti-apoptotic effects, and is used in a variety of diseases. However, it is unclear whether glutamine has an antioxidant or anti-apoptotic effect on melanocytes. Aims: The aim of this study was to investigate the protective effects of glutamine on a human melanocyte oxidative stress model. Methods: The oxidative stress model was established on human melanocytes using hydrogen peroxide. The morphology and viability of melanocytes, levels of oxidants [reactive oxygen species and malondialdehyde], levels of antioxidants [superoxide dismutase and glutathione-S-transferase], and apoptosis-related indicators (caspase-3, bax and bcl-2) were examined after glutamine exposure at various concentrations. Expressions of nuclear factor-E2-related factor 2, heme oxygenase-1, and heat shock protein 70 were detected using western blot technique after glutamine exposure at various concentrations. Results: Our results demonstrate that pre-treatment and post-treatment with glutamine promoted melanocyte viability, increased levels of superoxide dismutase, glutathione-S-transferase and bcl-2, decreased levels of reactive oxygen species, malondialdehyde, bax and caspase-3, and enhanced nuclear factor-E2-related factor 2, heme oxygenase-1, and heat shock protein 70 expression in a dose dependent manner. The effect of pre-treatment was more significant than post-treatment, at the same concentration. Limitations: The mechanisms of glutamine activated nuclear factor-E2-related factor 2 antioxidant responsive element signaling pathway need further investigation. Conclusions: Glutamine enhances the antioxidant and anti-apoptotic capabilities of melanocytes and protects them against oxidative stress.
  3,821 160 -
LETTERS TO THE EDITOR: LETTERS IN RESPONSE TO THE PREVIOUSLY PUBLISHED ARTICLES
Dermoscopy of lichen planus pigmentosus in Indian patients – Pitfalls to avoid
Sidharth Sonthalia, Enzo Errichetti, Feroze Kaliyadan, Abhijeet Kumar Jha, Aimilios Lallas
May-June 2018, 84(3):311-313
DOI:10.4103/ijdvl.IJDVL_40_18  PMID:29620038
  3,574 166 -
LETTERS TO THE EDITOR - OBSERVATION LETTERS
Angioma serpiginosum in a bilateral distribution with acral involvement: An uncommon presentation
Deepak Jakhar, Deepika Pandhi, Archana Singal, Sonal Sharma
May-June 2018, 84(3):338-341
DOI:10.4103/ijdvl.IJDVL_539_17  PMID:29547138
  3,616 59 -
NET LETTERS
Superficial granulomatous pyoderma: A great mimicker
Sheetanshu Kumar, Keshavamurthy Vinay, Davinder Parsad, Uma N Saikia, Muthu Sendhil Kumaran
May-June 2018, 84(3):374-374
DOI:10.4103/0378-6323.196317  PMID:28004648
  3,531 128 -
NET STUDY
Nail changes in autoimmune blistering disorders: A case-control study
Vaishnavi Gopal, Manjunath Mala Shenoy, Vishal Bejai, Thansiha Nargis
May-June 2018, 84(3):373-373
DOI:10.4103/ijdvl.IJDVL_19_17  PMID:29327699
Background: Pemphigus and pemphigoid disorders produce blistering cutaneous lesions. Earlier case reports state that nail involvement is uncommon in these autoimmune blistering disorders. Aims and Objectives: To study nail changes in autoimmune blistering disorders. Methods: A case-control study was conducted where 40 cases and 40 controls were evaluated for nail changes. Results: Nail changes were seen in 72.5% of cases and 17.5% of controls. The most common nail findings were paronychia and onychorrhexis. Limitations: Small sample size; short study duration; nail biopsy could not be done. Conclusion: Our findings indicate that the inflammatory nature of the blistering cutaneous disease is often reflected conspicuously in the nails.
  3,466 184 -
RESIDENTSí PAGE
Scholarships and travel grants for residents and young dermatologists from India
Keshavamurthy Vinay, Shraddha Uprety, Gitesh U Sawatkar
May-June 2018, 84(3):355-361
DOI:10.4103/ijdvl.IJDVL_450_17  PMID:29376511
  3,275 305 -
LETTERS TO THE EDITOR: LETTERS IN RESPONSE TO THE PREVIOUSLY PUBLISHED ARTICLES
Authors' reply
Vinod Kumar Sharma, Vishal Gupta, M Ramam
May-June 2018, 84(3):314-315
DOI:10.4103/ijdvl.IJDVL_103_18  PMID:29600797
  3,434 44 -
LETTERS TO THE EDITOR - OBSERVATION LETTERS
Oral lichenoid reactions to talcum powder: A usual report with unusual history
Santosh Palla, Vishwanath Rangdhol, Vandana Shekar, A Juhi Jahan
May-June 2018, 84(3):347-349
DOI:10.4103/ijdvl.IJDVL_159_17  PMID:29536979
  3,352 71 -
LETTERS TO THE EDITOR - THERAPY LETTER
A case of drug-induced hypersensitivity syndrome induced by icotinib managed by intravenous immunoglobulin and systemic corticosteroids
Xiaomei Chen, Sheng Wang, Li Li
May-June 2018, 84(3):350-352
DOI:10.4103/ijdvl.IJDVL_490_17  PMID:29516901
  3,105 53 -
IMAGES IN CLINICAL PRACTICE
Calcinosis cutis universalis in systemic sclerosis
Rashmi Modak, Vishalakshi Viswanath
May-June 2018, 84(3):353-354
DOI:10.4103/ijdvl.IJDVL_406_17  PMID:29451139
  2,824 110 -
NET LETTERS
Median raphe cyst of penis
Deepali Chandrakant Tarate, Swagata Arvind Tambe, Chitra Shivanand Nayak
May-June 2018, 84(3):373-373
DOI:10.4103/0378-6323.193627  PMID:27853003
  2,679 131 -
LETTERS TO THE EDITOR - CASE LETTERS
Anaplastic large cell non Hodgkin's lymphoma presenting as diffuse cutaneous hyperpigmentation
Sarita Sasidharanpillai, Ettappurath N Abdul Latheef, Poovullathil Jayesh Kumar, Puthen Parambath Sathi, Shiny P Manakkad, Pulpadathil Jishna, Thapron Smitha, Aparna S Vidya
May-June 2018, 84(3):316-320
DOI:10.4103/ijdvl.IJDVL_646_16  PMID:29536969
  2,625 67 -
LETTERS TO THE EDITOR - OBSERVATION LETTERS
A rare anatomical location of human papillomavirus-related penile warty carcinoma: Simultaneous axillary involvement
Ozay Ozkaya, Semra Karsidag, Mert Canli, Tufan Soydan, Damlanur Sakiz
May-June 2018, 84(3):336-338
DOI:10.4103/ijdvl.IJDVL_332_17  PMID:29536967
  2,547 42 -
IMAGES IN CLINICAL PRACTICE
Warty squamous cell carcinoma of glans penis
Tasleem Arif, Mohammad Adil, Noora Saeed
May-June 2018, 84(3):307-308
DOI:10.4103/ijdvl.IJDVL_155_17  PMID:29393077
  2,487 86 -
LETTERS TO THE EDITOR - OBSERVATION LETTERS
Extramammary Paget disease with histologic presence of epidermolytic hyperkeratosis: An unusual presentation
Anil Kumar Bhatta, Yeqiang Liu, Uma Keyal
May-June 2018, 84(3):341-344
DOI:10.4103/ijdvl.IJDVL_525_17  PMID:29536968
  2,453 63 -
CASE REPORT
Hodgkin's lymphoma arising in a case of mycosis fungoides: An unusual association
Preeti Sharma, Surbhi Goyal, Amit Kumar Yadav, Jasmeet Singh, Ashish Kumar Mandal
May-June 2018, 84(3):292-297
DOI:10.4103/ijdvl.IJDVL_744_16  PMID:29098990
Mycosis fungoides is a cutaneous T-cell lymphoma with a high risk for developing secondary malignancies, especially B-cell lymphoproliferative disorders. About 40 cases of Hodgkin's lymphoma associated with mycosis fungoides have been reported in literature till date. We report a case of a 35-year-old gentleman who presented with intensely itchy reddish lesions all over the body. Multiple skin biopsies taken from the lesions on scalp and back confirmed the clinical diagnosis of mycosis fungoides. While on treatment, he presented with multiple bilateral cervical, axillary and inguinal lymphadenopathy 9 years after the primary diagnosis of mycosis fungoides. Excision biopsy of a cervical lymph node revealed partial effacement of architecture by a tumor comprising polymorphous background. Histopathology and immunohistochemistry revealed a diagnosis of Hodgkin's lymphoma - nodular sclerosis subtype. The patient was started on chemotherapy for stage IV Hodgkin's lymphoma. Our case emphasizes the importance of keeping secondary Hodgkin's lymphoma in mind while dealing with a patient of mycosis fungoides. Our case immunohistochemically supports the distinct etiopathogenesis of Epstein–Barr virus-negative Hodgkin's lymphoma vis-à-vis cutaneous mycosis fungoides.
  2,395 107 -
NET LETTERS
Cancrum oris (noma): An early sign of acute lymphoblastic leukemia relapse
Irappa Madabhavi, Swaroop Revannasiddaiah, Malay Sarkar
May-June 2018, 84(3):373-373
DOI:10.4103/ijdvl.IJDVL_1038_14  PMID:28799529
  2,313 100 -
QUIZ
Painful ulcer of the pinna in an immunocompromised patient
E Gómez Moyano, M Ayala Blanca, F Jiménez Oñate, L Martínez Pilar
May-June 2018, 84(3):369-372
DOI:10.4103/ijdvl.IJDVL_806_16  PMID:29067931
  2,235 110 -
CASE REPORT
Disseminated cutaneous fusariosis in human immunodeficiency virus-infected patient and dramatic response with oral itraconazole
Indu Kumari, Satyendra Kumar Singh, Rishabh Kumar Chauhan, Satyendra Kumar Kaushal
May-June 2018, 84(3):362-368
DOI:10.4103/ijdvl.IJDVL_360_16  PMID:29327700
Fusarium species are known to cause disseminated cutaneous lesions in immunocompromised patients. Some cases of fusariosis are reported in patients infected with the human immunodeficiency virus. There are two reports in such patients with systemic comorbidities like lymphoma, neutropenia and infective port-a-catheter. Another reported patient had systemic fusariosis, without skin involvement. Diagnosis and treatment of cutaneous fusariosis is difficult and resistance to antifungals is a problem. Our patient was at an advanced human immunodeficiency virus infection stage with disseminated cutaneous fusariosis, without any systemic involvement, who responded completely to oral itraconazole.
  2,238 79 -
ORIGINAL ARTICLES
Association of interleukin 1 receptor antagonist intron 2 variable number of tandem repeats polymorphism with vitiligo susceptibility in Gujarat population
Mala Singh, Mohmmad Shoab Mansuri, Shahnawaz D Jadeja, Yogesh S Marfatia, Rasheedunnisa Begum
May-June 2018, 84(3):285-291
DOI:10.4103/ijdvl.IJDVL_1_17  PMID:29620037
Background: Vitiligo is a multifactorial, polygenic, autoimmune skin disorder caused by selective destruction of melanocytes. Interleukin 1 receptor antagonist intron 2 polymorphism was found to be associated with various autoimmune disorders. Aims: We aimed to investigate the association of interleukin 1 receptor antagonist intron 2 variable number of tandem repeats polymorphism (rs2234663) with vitiligo to assess interleukin 1 receptor antagonist transcript levels and to perform possible genotype–phenotype correlation. Methods: Three hundred and seven vitiligo patients and 316 controls were enrolled in the study, genotyping of interleukin 1 receptor antagonist rs2234663 was performed by polymerase chain reaction, and relative gene expression of interleukin 1 receptor antagonist was carried out in peripheral blood mononuclear cells from patients (n = 36) and controls (n = 36) by real-time-PCR. Results: A significant difference was observed in the frequency of interleukin 1 receptor antagonist *A (1/2) genotype among patients with active and stable vitiligo (P = 0.0172). Interleukin 1 receptor antagonist*A (2/2) genotype and allele frequencies were significantly different between SV patients and controls (P = 0.0246 and P = 0.0046, respectively). Significant difference was also observed for interleukin 1 receptor antagonist*A2 (allele) in active and stable vitiligo patients (P = 0.0060). However, other comparisons did not show any significant difference in genotype and allele frequencies. Moreover, interleukin 1 receptor antagonist*A (3/2) genotype was observed only in patients whereas interleukin 1 receptor antagonist*A (5/2) was observed only in controls. Gene expression analysis showed no significant difference in interleukin 1 receptor antagonist transcript levels in patients compared to controls (P = 0.5962). Interestingly, genotype–phenotype correlation analysis revealed that individuals with IL1RN*A (2/2) exhibited higher interleukin 1 receptor antagonist expression compared to other major genotypes interleukin 1 receptor antagonist*A (1/2) (P = 0.01) and interleukin 1 receptor antagonist*A (1/1) (P = 0.03). Limitations: More case-control studies on interleukin 1 receptor antagonist rs2234663 polymorphism and gene expression from different ethnic populations are required to explore the impact of interleukin 1 receptor antagonist in vitiligo susceptibility. Conclusion: Interleukin 1 receptor antagonist*A2 might be a risk factor for progressive vitiligo.
  2,241 75 -
LETTERS TO THE EDITOR - STUDY LETTERS
Clinical profile and virology analysis of hand, foot and mouth disease cases from North Kerala, India in 2015–2016: A tertiary care hospital-based cross-sectional study
Sasidharanpillai Sabitha, Sarita Sasidharanpillai, Ramachandran E Sanjay, Manikoth Payyanadan Binitha, Najeeba Riyaz, Kunnummal Muhammed, Tapron Smitha, Aparna S Vidya, Kambiam Veettil Vaishnavi, Thalekkara Madhavan Saranya, Govindakaranavar Arunkumar
May-June 2018, 84(3):328-331
DOI:10.4103/ijdvl.IJDVL_579_17  PMID:29620046
  2,086 84 -
QUIZ
Steroid-resistant erythroderma and alopecia in a newborn
Rana A El Khoury, Elie H Maalouf, Elio G Kechichian, Roland R Tomb
May-June 2018, 84(3):304-306
DOI:10.4103/ijdvl.IJDVL_666_16  PMID:28836510
  1,973 138 -
LETTERS TO THE EDITOR - CASE LETTERS
Recurrent unilateral angiolymphoid hyperplasia with eosinophilia in pregnancy
Sudha Vani Damarla, Sudha Rani Chintagunta, Geeta Kiran Arakkal
May-June 2018, 84(3):325-327
DOI:10.4103/ijdvl.IJDVL_405_17  PMID:29620039
  1,805 67 -
LETTERS TO THE EDITOR - OBSERVATION LETTERS
Reticular telangiectatic erythema associated with implantable automatic cardioverter defibrillator
Ximena Calderón-Castrat, Javier Cañueto, Concepción Román-Curto, Ángel Santos-Briz, Emilia Fernández-López
May-June 2018, 84(3):334-336
DOI:10.4103/ijdvl.IJDVL_933_16  PMID:29451140
  1,626 16 -
BRIEF REPORT
Paraffin-embedded micrographic surgery for the treatment of dermatofibrosarcoma protuberans: Analysis of 33 patients
Adriana Martín-Fuentes, Esther De Eusebio-Murillo, Consuelo Sánchez Herreros, Adrian Ballano-Ruiz, Esther Jiménez Blázquez, Jesús Cuevas-Santos
May-June 2018, 84(3):298-303
DOI:10.4103/0378-6323.190853  PMID:27643548
Background: Dermatofibrosarcoma protuberans is a rare malignant tumor with a high rate of recurrence after surgery. Moh's micrographic surgery allows examination of all surgical margins to ensure complete removal. Objective: To evaluate the use of Moh's micrographic surgery using paraffin-embedded sections for the treatment of dermatofibrosarcoma protuberans. Methods: We performed a retrospective analysis of 33 patients with dermatofibrosarcoma protuberans treated in our department with paraffin-embedded micrographic surgery between January 2002 and June 2015. Our cases included patients with primary untreated disease and also those with persistent disease previously treated surgically elsewhere, with histologically positive margins. Results: Tumors were most commonly located on the trunk. After the first stage of micrographic surgery, including an initial lateral margin, 20 (60.6%) tumors were completely excised, 11 (33.3%) tumors required two stages and one tumor each (3.0%) required 4 and 6 stages respectively. Patients were monitored for recurrence for a mean duration of 6.5 years. There was no recurrence in any of our 33 patients. Conclusions: Our results indicate that Moh's micrographic surgery with paraffin-embedded sections may be the method of choice to treat dermatofibrosarcoma protuberans with a low recurrence rate, while preserving surrounding normal healthy tissue.
  1,565 59 -
LETTERS TO THE EDITOR: LETTERS IN RESPONSE TO THE PREVIOUSLY PUBLISHED ARTICLES
In response to “Effectiveness of topical green tea against multidrug-resistant Staphylococcus aureus in cases of primary pyoderma: An open controlled trial”
Debabrata Bandyopadhyay
May-June 2018, 84(3):309-310
DOI:10.4103/ijdvl.IJDVL_158_18  PMID:29620047
  1,469 48 -
ERRATA
Erratum: Intracutaneous pharmacokinetics of oral antifungals and their relevance in recalcitrant cutaneous dermatophytosis: Time to revisit basics

May-June 2018, 84(3):387-387
DOI:10.4103/0378-6323.216935  PMID:29657191
  1,204 90 -
LETTERS TO THE EDITOR: LETTERS IN RESPONSE TO THE PREVIOUSLY PUBLISHED ARTICLES
Authors' reply
Nagaraju Umashankar, Belliappa Pemmanda, P Gopkumar, AJ Hemalatha, KS Priya, HV Prashanth
May-June 2018, 84(3):310-310
DOI:10.4103/ijdvl.IJDVL_259_18  PMID:29620045
  1,211 39 -
Online since 15th March '04
Published by Wolters Kluwer - Medknow